Entertainment » OtherPosted at: May 30 2016 2:51PM Hyderabad-based Granules plant receives EIR from US FDAHyderabad, May 30 (UNI) Granules India Ltd., a growing pharmaceutical manufacturing company, announced today that it has received the Establishment Inspection Report (EIR) from the US FDA for the inspection conducted at its Jeedimetla facility in Hyderabad in December last year. In a statement, the Company stated that, the US FDA acknowledged receipt of its responses sent on January 7 and March 28 this year on the observations issued by the US FDA for the Jeedimetla facility. The US FDA closed the matter and issued Establishment Inspection Report (EIR) for the Jeedimetla facility situated in the state of Telangana state.Please log in to get detailed story.Tags: #Hyderabad-based Granules plant receives EIR from US FDA